ns 1619 has been researched along with Heart Disease, Ischemic in 2 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xu, W | 1 |
Liu, Y | 1 |
Wang, S | 1 |
McDonald, T | 1 |
Van Eyk, JE | 1 |
Sidor, A | 1 |
O'Rourke, B | 1 |
Wang, X | 1 |
Yin, C | 1 |
Xi, L | 1 |
Kukreja, RC | 1 |
2 other studies available for ns 1619 and Heart Disease, Ischemic
Article | Year |
---|---|
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane.
Topics: Adenosine Triphosphate; Animals; Benzimidazoles; Calcium; Charybdotoxin; Cytoprotection; Guinea Pigs | 2002 |
Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice.
Topics: Animals; Animals, Outbred Strains; Benzimidazoles; Cardiotonic Agents; Ischemic Preconditioning, Myo | 2004 |